Bli medlem
Bli medlem

Du är här

2016-11-02

Novavax, Inc.: UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016

Financial results conference call will include Investor and Analyst webcast
presentation

GAITHERSBURG, Md., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX) today announced it will host an Investor and Analyst update as
part of its third quarter financial results conference call and webcast after
the close of U.S. financial markets on Wednesday, November 9, 2016.

Management will host a conference call to discuss the quarterly financial
results and provide an update on corporate activities. Please be sure to join
the webcast in order to access the slide presentation.

Conference call details are as follows:

--------------------------------------------------------------------------------
| Date: Wednesday, November 9, 2016 |
| Time: 4:30 p.m. U.S. Eastern Time (ET) |
| Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International) |
| Passcode: 10126707 |
| Webcast: www.novavax.com, "Investors"/ "Events" |
| |
--------------------------------------------------------------------------------
Conference call replay:

---------------------------------------------------------------------------------------
| Dates: Starting at 8:30 p.m. ET, November 9, 2016 until November 16, 2016 |
| Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International) |
| Passcode: 10126707 |
| Webcast: www.novavax.com, "Investors"/ "Events" |
| |
---------------------------------------------------------------------------------------
About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases.
Its recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines.
Contact:
Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

ir@novavax.com
240-268-2000

---------------------------------------
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.